Sleep Initiation and Maintenance Disorders Completed Phase 4 Trials for Fluoxetine (DB00472)

IndicationStatusPhase
DBCOND0029149 (Sleep Initiation and Maintenance Disorders)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00247624Improving Sleep and Psychological Functioning in People With Depression and InsomniaTreatment